Literature DB >> 25691632

Amplification of pfmdr1, pfcrt, pvmdr1, and K13 propeller polymorphisms associated with Plasmodium falciparum and Plasmodium vivax isolates from the China-Myanmar border.

Jun Feng1, Daili Zhou2, Yingxue Lin2, Huihui Xiao1, He Yan1, Zhigui Xia3.   

Abstract

Malaria in the China-Myanmar border region is still severe; local transmission of both falciparum and vivax malaria persists, and there is a risk of geographically expanding antimalarial resistance. In this research, the pfmdr1, pfcrt, pvmdr1, and K13-propeller genotypes were determined in 26 Plasmodium falciparum and 64 Plasmodium vivax isolates from Yingjiang county of Yunnan province. The pfmdr1 (11.5%), pfcrt (34.6%), and pvmdr1 (3.1%) mutations were prevalent at the China-Myanmar border. The indigenous samples exhibited prevalences of 14.3%, 28.6%, and 14.3% for pfmdr1 N86Y, pfcrt K76T, and pfcrt M74I, respectively, whereas the samples from Myanmar showed prevalences of 10.5%, 21.1%, and 5.3%, respectively. The most prevalent genotypes of pfmdr1 and pfcrt were Y86Y184 and M74N75T76, respectively. No pvmdr1 mutation occurred in the indigenous samples but was observed in two cases coming from Myanmar. In addition, we are the first to report on 10 patients (38.5%) with five different K13 point mutations. The F446I allele is predominant (19.2%), and its prevalence was 28.6% in the indigenous samples of Yingjiang county and 15.8% in samples from Myanmar. The present data might be helpful for enrichment of the molecular surveillance of antimalarial resistance and useful for developing and updating guidance for the use of antimalarials in this region.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25691632      PMCID: PMC4394781          DOI: 10.1128/AAC.04843-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Intercontinental spread of pyrimethamine-resistant malaria.

Authors:  Cally Roper; Richard Pearce; Shalini Nair; Brian Sharp; François Nosten; Tim Anderson
Journal:  Science       Date:  2004-08-20       Impact factor: 47.728

2.  Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar.

Authors:  Mallika Imwong; Sasithon Pukrittayakamee; Wirichada Pongtavornpinyo; Supatchara Nakeesathit; Shalini Nair; Paul Newton; Francois Nosten; Timothy J C Anderson; Arjen Dondorp; Nicholas P J Day; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

3.  Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity.

Authors:  Sara Brega; Benoit Meslin; Frédérique de Monbrison; Carlo Severini; Luigi Gradoni; Rachanee Udomsangpetch; Inge Sutanto; François Peyron; Stéphane Picot
Journal:  J Infect Dis       Date:  2004-12-09       Impact factor: 5.226

4.  Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.

Authors:  Amar Bir Singh Sidhu; Anne-Catrin Uhlemann; Stephanie G Valderramos; Juan-Carlos Valderramos; Sanjeev Krishna; David A Fidock
Journal:  J Infect Dis       Date:  2006-07-11       Impact factor: 5.226

5.  Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar.

Authors:  Jean-Paul Guthmann; Anne Pittet; Alexandre Lesage; Mallika Imwong; Niklas Lindegardh; Myo Min Lwin; Than Zaw; Anna Annerberg; Xavier de Radiguès; François Nosten
Journal:  Trop Med Int Health       Date:  2008-01       Impact factor: 2.622

Review 6.  The origins of antimalarial drug resistance.

Authors:  Ian M Hastings
Journal:  Trends Parasitol       Date:  2004-11

7.  Clinical trials of artemisinin and its derivatives in the treatment of malaria in China.

Authors:  G Q Li; X B Guo; L C Fu; H X Jian; X H Wang
Journal:  Trans R Soc Trop Med Hyg       Date:  1994-06       Impact factor: 2.184

8.  Changes in susceptibility of Plasmodium falciparum to artesunate in vitro in Yunnan Province, China.

Authors:  Henglin Yang; Dequan Liu; Yaming Yang; Bo Fan; Pinfang Yang; Xingliang Li; Chunfu Li; Ying Dong; Cangjiang Yang
Journal:  Trans R Soc Trop Med Hyg       Date:  2003 Mar-Apr       Impact factor: 2.184

9.  Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.

Authors:  Frank Smithuis; Maryam Shahmanesh; Moe Kyaw Kyaw; Olivia Savran; Saw Lwin; Nicholas J White
Journal:  Trop Med Int Health       Date:  2004-11       Impact factor: 2.622

10.  Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border.

Authors:  Chansuda Wongsrichanalai; Steven R Meshnick
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

View more
  26 in total

Review 1.  Understanding artemisinin-resistant malaria: what a difference a year makes.

Authors:  Rick M Fairhurst
Journal:  Curr Opin Infect Dis       Date:  2015-10       Impact factor: 4.915

2.  Artemisinin resistance-associated markers in Plasmodium falciparum parasites from the China-Myanmar border: predicted structural stability of K13 propeller variants detected in a low-prevalence area.

Authors:  Yan He; Susana Campino; Ernest Diez Benavente; David C Warhurst; Khalid B Beshir; Inke Lubis; Ana Rita Gomes; Jun Feng; Wang Jiazhi; Xiaodong Sun; Fang Huang; Lin-Hua Tang; Colin J Sutherland; Taane G Clark
Journal:  PLoS One       Date:  2019-03-18       Impact factor: 3.240

3.  Polymorphisms in Plasmodium falciparum Kelch 13 and P. vivax Kelch 12 Genes in Parasites Collected from Three South Pacific Countries Prior to Extensive Exposure to Artemisinin Combination Therapies.

Authors:  Karryn Gresty; Karen Anderson; Cielo Pasay; Norman C Waters; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

4.  Genetic diversity of the Plasmodium vivax phosphatidylinositol 3-kinase gene in two regions of the China-Myanmar border.

Authors:  Huguette Gaelle Ngassa Mbenda; Weilin Zeng; Yao Bai; Faiza Amber Siddiqui; Zhaoqing Yang; Liwang Cui
Journal:  Infect Genet Evol       Date:  2018-02-17       Impact factor: 3.342

Review 5.  An analysis of Plasmodium falciparum-K13 mutations in India.

Authors:  Laxman Kumar Murmu; Tapan Kumar Barik
Journal:  J Parasit Dis       Date:  2021-08-02

6.  Prevalence of Plasmodium falciparum Kelch 13 (PfK13) and Ubiquitin-Specific Protease 1 (pfubp1) Gene Polymorphisms in Returning Travelers from Africa Reported in Eastern China.

Authors:  He Yan; Xiangli Kong; Tao Zhang; Huihui Xiao; Xinyu Feng; Hong Tu; Jun Feng
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

Review 7.  Artemisinin-Resistant Plasmodium falciparum Malaria.

Authors:  Rick M Fairhurst; Arjen M Dondorp
Journal:  Microbiol Spectr       Date:  2016-06

8.  A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.

Authors:  Didier Ménard; Nimol Khim; Johann Beghain; Ayola A Adegnika; Mohammad Shafiul-Alam; Olukemi Amodu; Ghulam Rahim-Awab; Céline Barnadas; Antoine Berry; Yap Boum; Maria D Bustos; Jun Cao; Jun-Hu Chen; Louis Collet; Liwang Cui; Garib-Das Thakur; Alioune Dieye; Djibrine Djallé; Monique A Dorkenoo; Carole E Eboumbou-Moukoko; Fe-Esperanza-Caridad J Espino; Thierry Fandeur; Maria-Fatima Ferreira-da-Cruz; Abebe A Fola; Hans-Peter Fuehrer; Abdillahi M Hassan; Socrates Herrera; Bouasy Hongvanthong; Sandrine Houzé; Maman L Ibrahim; Mohammad Jahirul-Karim; Lubin Jiang; Shigeyuki Kano; Wasif Ali-Khan; Maniphone Khanthavong; Peter G Kremsner; Marcus Lacerda; Rithea Leang; Mindy Leelawong; Mei Li; Khin Lin; Jean-Baptiste Mazarati; Sandie Ménard; Isabelle Morlais; Hypolite Muhindo-Mavoko; Lise Musset; Kesara Na-Bangchang; Michael Nambozi; Karamoko Niaré; Harald Noedl; Jean-Bosco Ouédraogo; Dylan R Pillai; Bruno Pradines; Bui Quang-Phuc; Michael Ramharter; Milijaona Randrianarivelojosia; Jetsumon Sattabongkot; Abdiqani Sheikh-Omar; Kigbafori D Silué; Sodiomon B Sirima; Colin Sutherland; Din Syafruddin; Rachida Tahar; Lin-Hua Tang; Offianan A Touré; Patrick Tshibangu-wa-Tshibangu; Inès Vigan-Womas; Marian Warsame; Lyndes Wini; Sedigheh Zakeri; Saorin Kim; Rotha Eam; Laura Berne; Chanra Khean; Sophy Chy; Malen Ken; Kaknika Loch; Lydie Canier; Valentine Duru; Eric Legrand; Jean-Christophe Barale; Barbara Stokes; Judith Straimer; Benoit Witkowski; David A Fidock; Christophe Rogier; Pascal Ringwald; Frederic Ariey; Odile Mercereau-Puijalon
Journal:  N Engl J Med       Date:  2016-06-23       Impact factor: 91.245

9.  Characterization of pfmdr1, pfcrt, pfK13, pfubp1, and pfap2mu in Travelers Returning from Africa with Plasmodium falciparum Infections Reported in China from 2014 to 2018.

Authors:  Jun Feng; Dongmei Xu; Xiangli Kong; Kangming Lin; He Yan; Xinyu Feng; Hong Tu; Zhigui Xia
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

10.  Prevalence of K13-propeller polymorphisms in Plasmodium falciparum from China-Myanmar border in 2007-2012.

Authors:  Zenglei Wang; Sony Shrestha; Xiaolian Li; Jun Miao; Lili Yuan; Mynthia Cabrera; Caitlin Grube; Zhaoqing Yang; Liwang Cui
Journal:  Malar J       Date:  2015-04-18       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.